Inhibition of toll-like receptor 4 by allicin suppresses mitochondrial DNA-mediated inflammation and pyroptosis to alleviate myocardial ischemia-reperfusion injury
- 29 June 2026
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 159, 158513
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81873138)
- National Natural Science Foundation of China (82274331)
This publication has 34 references indexed in Scilit:
- Therapeutic role of allicin in gastrointestinal cancers: mechanisms and safety aspectsDiscover Oncology, 2025
- Melatonin ameliorates myocardial ischemia/reperfusion injury via regulating the ubiquitin-proteasome systemLife Sciences, 2025
- Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathwayImmunity, 2025
- Splenic monocytes mediate inflammatory response and exacerbate myocardial ischemia/reperfusion injury in a mitochondrial cell-free DNA-TLR9-NLRP3-dependent fashionBasic Research in Cardiology, 2023
- Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarctionBiomedicine & Pharmacotherapy, 2023
- Myocardial ischemia-reperfusion injury and the influence of inflammationTrends in Cardiovascular Medicine, 2022
- Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagyJournal of Molecular Medicine, 2018
- The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence AnalysesCurrent Protocols in Bioinformatics, 2016
- Innate immunity and cardiomyocytes in ischemic heart diseaseLife Sciences, 2014
- Sequential Expression of TLR4 and its Effects on the Myocardium of Rats with Myocardial Ischemia-Reperfusion InjuryInflammation, 2008